1. Home
  2. HBM vs GKOS Comparison

HBM vs GKOS Comparison

Compare HBM & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudbay Minerals Inc. (Canada)

HBM

Hudbay Minerals Inc. (Canada)

HOLD

Current Price

$19.08

Market Cap

7.2B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$104.98

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBM
GKOS
Founded
1927
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.0B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
HBM
GKOS
Price
$19.08
$104.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
14
Target Price
$25.00
$133.07
AVG Volume (30 Days)
5.2M
606.9K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
0.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$29.94
$23.34
Revenue Next Year
$13.16
$27.46
P/E Ratio
$21.47
N/A
Revenue Growth
N/A
32.33
52 Week Low
$5.95
$73.16
52 Week High
$28.74
$130.23

Technical Indicators

Market Signals
Indicator
HBM
GKOS
Relative Strength Index (RSI) 37.60 45.83
Support Level $14.66 $81.54
Resistance Level $28.64 $104.66
Average True Range (ATR) 0.96 4.10
MACD -0.12 0.57
Stochastic Oscillator 27.49 61.22

Price Performance

Historical Comparison
HBM
GKOS

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a copper-focused critical minerals company with three long-life operations and a pipeline of copper growth projects in Canada, Peru, and the United States. Its operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada), and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by gold, zinc, silver, and molybdenum production. Hudbay's growth pipeline includes the Copper World project and the Mason project in the USA, and the Llaguen project in Peru. The company's reportable segments are: Peru, which generates the maximum revenue, Manitoba, British Columbia, and Arizona. Geographically, it generates maximum revenue from China and Canada.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: